Clinical Trial Update: Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (Control Levels)

View source ↗

Summary

Completed clinical trial evaluating the clinical utility of serum biomarkers to guide management of neonatal Hypoxic Ischemic Encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Snippet

Sponsor: University of Florida | Conditions: Hypoxic Ischemic Encephalopathy | Status: COMPLETED